Search research articles
Contact Us
Filters
Showing results (1-10 of 169) with videos related to
Page
of 17
Sort By:
Intervirology
|
January 31, 2012
The XTrack system: application and advantage
Thomas Klimkait
American Clinical Laboratory
|
April 27, 2002
A sensitive replicative system to assess HIV-1 drug resistance
Thomas Klimkait
Viruses
|
December 23, 2022
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses
Christian Mittelholzer, Thomas Klimkait
Antiviral Therapy
|
November 30, 2005
Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration
David Dalmau, Thomas Klimkait, Amalio Telenti
Antiviral Therapy
|
February 25, 2015
Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping
Sarah Wagner, Mario Kurz, Thomas Klimkait, et al.
Journal of Biochemistry and Molecular Biology
|
September 26, 2002
A neutravidin-based assay for reverse transcriptase suitable for high throughput screening of retroviral activity
Lyndall E Brennan, Carlos Suñé, Thomas Klimkait
Journal of Clinical Microbiology
|
November 19, 2013
Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study
Jörg Berg, Christian Paar, Heribert Stoiber, et al.
FEBS Letters
|
October 7, 2003
Enhanced gene silencing by the application of multiple specific small interfering RNAs
Jingmin Ji, Marion Wernli, Thomas Klimkait, et al.
Biochemical and Biophysical Research Communications
|
January 27, 2005
The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability
Vincent Brondani, Quirino Schefer, François Hamy, et al.
Journal of Molecular Biology
|
June 11, 2002
Promoter of FGF8 reveals a unique regulation by unliganded RARalpha
Vincent Brondani, Thomas Klimkait, Jean-Marc Egly, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 169) with videos related to
Sort By:
Page
of 17
Intervirology
|
January 31, 2012
The XTrack system: application and advantage
Thomas Klimkait
American Clinical Laboratory
|
April 27, 2002
A sensitive replicative system to assess HIV-1 drug resistance
Thomas Klimkait
Viruses
|
December 23, 2022
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses
Christian Mittelholzer, Thomas Klimkait
Antiviral Therapy
|
November 30, 2005
Opinion paper. Resistance to new anti-HIV agents: problems in the pathway of drug registration
David Dalmau, Thomas Klimkait, Amalio Telenti
Antiviral Therapy
|
February 25, 2015
Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping
Sarah Wagner, Mario Kurz, Thomas Klimkait, et al.
Journal of Biochemistry and Molecular Biology
|
September 26, 2002
A neutravidin-based assay for reverse transcriptase suitable for high throughput screening of retroviral activity
Lyndall E Brennan, Carlos Suñé, Thomas Klimkait
Journal of Clinical Microbiology
|
November 19, 2013
Issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the Maraviroc Switch collaborative study
Jörg Berg, Christian Paar, Heribert Stoiber, et al.
FEBS Letters
|
October 7, 2003
Enhanced gene silencing by the application of multiple specific small interfering RNAs
Jingmin Ji, Marion Wernli, Thomas Klimkait, et al.
Biochemical and Biophysical Research Communications
|
January 27, 2005
The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability
Vincent Brondani, Quirino Schefer, François Hamy, et al.
Journal of Molecular Biology
|
June 11, 2002
Promoter of FGF8 reveals a unique regulation by unliganded RARalpha
Vincent Brondani, Thomas Klimkait, Jean-Marc Egly, et al.
Page
of 17